Tag:
Ozempic
News
Stopping Ozempic may increase the risk of heart attack and stroke — study
Discontinuing GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) significantly increases patients’ risk of cardiovascular disease. According to a new study by Washington University in St....
News
Ozempic Slashes Asthma Attacks by 40%, Groundbreaking Real-World Study Reveals
Semaglutide—the active compound powering household blockbuster drugs Ozempic and Wegovy—delivers a surprising, vital shield for respiratory health. A massive UK health records study presented...
News
Ozempic, Wegovy and other GLP-1 agonists: What mistakes do patients make when using these medications?
GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy), liraglutide, dulaglutide, and tirzepatide, are currently considered among the most effective pharmacotherapies for the management of obesity....
Neurology
Ozempic is effective against addictions: Scientists have discovered the mechanism of how weight loss drugs affect the brain
Next-generation weight-loss and diabetes medications (GLP-1 receptor agonists), such as Ozempic and Wegovy, are increasingly capturing the attention of neuroscientists. Clinical and preclinical studies...
News
Ozempic and Wegovy to become 50% cheaper: Novo Nordisk plans to halve prices starting from 2027
The Danish pharmaceutical giant, Novo Nordisk, has made a significant decision: starting in 2027, the company will reduce prices by up to 50% for...
News
Study: Ozempic improves blood sugar control and weight loss in patients on antipsychotic treatment
According to a new study published in the journal JAMA Psychiatry, medications containing semaglutide, such as Ozempic and Wegovy, have the potential to significantly...